Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,470.00
(
-1.06%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
106.93
(
0.00%
)
Bitcoin
70,510.01
(
-0.01%
)
News Focus
News Focus

Replies to post #180141 on Biotech Values

Replies to #180141 on Biotech Values
icon url

DewDiligence

09/16/15 1:40 PM

#195064 RE: DewDiligence #180141

BMY’s approved 2-DAA HCV regimen in Japan is showing a 20% failure rate, according to John Milligan on GILD’s MS webcast today.